R1 RCM vs Veradigm
Two End-to-End RCM vendors, side by side. Facts from public sources; judgments are ours.
At a glance
Derived from public facts · a rough scale, not a ranking
| R1 RCM | Veradigm | |
|---|---|---|
| Pricing model | Percent of collections · roughly 4-7% of net collections | Enterprise contract (custom) · Varies by product line |
| Speed to go live | full outsourcing with staff transitions | Clearinghouse light; EHR and RCM heavier |
| Automation model | Tech-enabled service · embedded teams plus AI automation | Software platform · Software plus data network and services |
| Built for | Enterprise systems | Small practices, Mid-size groups, Enterprise systems, Payers |
| Security posture | HITRUST, SOC 2 Type II, PCI DSS, HIPAA | SOC 2 Type II, HIPAA |
| Company maturity | 23 yrs (est. 2003) | 40 yrs (est. 1986) |
| Financial backing | PE-owned (TowerBrook and CD&R) | Public (OTC: MDRX) |
| Named customers | 4 named | None public |
| Published results | No public numbers | No public numbers |
| Documented integrations | 4 listed | 4 listed |
| Third-party validation | None found | None found |
Bottom line
- Pick R1 RCM if you are a hospital or health system ready to hand the entire revenue cycle to an outside operator, staff included.
- Pick Veradigm if you want a proven clearinghouse and ambulatory RCM stack from one vendor and can tolerate its corporate and financial-reporting turbulence.
R1 RCM
The largest end-to-end RCM operator
- Founded
- 2003
- HQ
- Murray, UT
- Stage
- PE-owned (TowerBrook and CD&R)
- Raised
- n/a
What it does
- Full outsourced revenue cycle operations, front door to final payment
- Patient access, scheduling, and registration services at scale
- Coding, billing, denials management, and underpayment recovery
- Cloudmed revenue intelligence mines charts for missed revenue
- R37 lab building agentic AI for coding and denials
- Modular offerings for physician groups and hospitals
Where it's strong
- Unmatched scale and data: serves 94 of the top 100 health systems and processes 550 million patient encounters a year.
- Can take over the entire revenue cycle including staff, which few vendors can credibly offer a large health system.
- The exclusive Palantir partnership (R37) gives it a serious platform for agentic AI across coding, billing, and denials.
What buyers should weigh
- Full outsourcing means deep operational dependence; unwinding an R1 contract is a multi-year project.
- Built for large health systems; small and mid-size groups are not the core market and get less attention.
- PE ownership after the $8.9B take-private adds margin pressure, and the company has weathered customer disputes and a 2024 cyberattack ripple from partners.
Named customers
Ascension · Intermountain Health · AMITA Health · Quorum Health
Integrations
Veradigm
Ambulatory RCM, clearinghouse network, and healthcare data at scale
- Founded
- 1986
- HQ
- Chicago, IL
- Stage
- Public (OTC: MDRX)
- Raised
- n/a
What it does
- Payerpath clearinghouse serving 300,000+ providers
- Outsourced RCM services (Koha Health acquisition)
- Veradigm EHR and Practice Fusion for ambulatory care
- AI Ambient Scribe for clinical documentation
- Payer analytics and risk adjustment
- Real-world data for life sciences research
Where it's strong
- Payerpath is repeatedly ranked the top physician claims clearinghouse by Black Book.
- One vendor covers EHR, clearinghouse, RCM services, and an ambient scribe for ambulatory groups.
- Its provider network gives it data assets few RCM vendors can match.
What buyers should weigh
- Accounting failures got the stock delisted from Nasdaq in 2024; it still trades OTC while restating financials.
- Strategic uncertainty lingers after an abandoned sale process and repeated leadership changes.
- The EHR products are legacy Allscripts assets with slower innovation than newer rivals.
Integrations
Compare against the rest of End-to-End RCM
Deciding between these two?
First Pass tracks End-to-End RCM every week: funding, launches, and what changed since this page was written.